The development of germ cells can be divided into two phases. The first phases involves the fetal and neonatal phases of germ cell development that lead to the formation of the SSCs. The second phase is
spermatogenesis, which is a cycle of regulated
mitosis,
meiosis and differentiation (via
spermiogenesis) leading to the production of mature
spermatozoa, also known as sperm cells. Gonocytes are functionally present during the first phase of germ cell maturation and development. and the gonocytes, which after being differentiated from PGCs, undergo regulated proliferation, differentiation, migration and apoptosis to produce the SSCs. In between E7.5 and E12.5, these PGCs migrate towards the
genital ridge, where they form the
testicular cords, via the
cytokine interactions of the
CXCR4 and
c-Kit membrane receptors and their ligands
SDF1 and SCF respectively. During this migratory period, PGCs undergo
epigenetic reprogramming through
genome-wide
DNA demethylation. It is only after these developmental steps that the germ cells present in the developed testicular cords are identified as gonocytes. Moreover, RA inhibited differentiation by stopping the fetal gonocytes from entering mitotic arrest while simultaneously triggering apoptosis. RA, by decreasing the overall fetal gonocyte population via apoptosis, is speculated to allow the elimination of
mutated and dysfunctional germ cells. There are a number of factors that influence neonatal gonocyte proliferation, including
17β‐estradiol (E2),
Leukemia inhibitory factor (LIF),
platelet-derived growth factor (PDGF)-BB, and RA. The production of PDGF-BB and E2 by surrounding Sertoli cells activate their respective receptors on neonatal gonocytes, triggering proliferation via an interactive, crosstalk mechanism. The regulation of LIF is speculated to allow gonocytes to become sensitive to Sertoli cell factors that trigger proliferation, such as PDGF-BB and E2. Compared to fetal gonocytes, RA exerts a similar functional role in neonatal gonocytes; It simultaneously stimulates proliferation and apoptosis for regulation of gonocyte and future SSCs population. Although c-Kit expression is evident in a small fraction of neonatal gonocytes, they also express of
PDGF receptor beta (PDGFRβ) on their membrane to aid in their migration. Inhibition of PDGF receptors and c-Kit by
in vivo treatment of
imatinib, an inhibitory
drug, interrupted migration, leading to a number of gonocytes centrally located in the seminiferous cords.
Differentiation The differentiation of gonocytes to SSC only occur once the cells have established close contact with the basement membrane in the seminiferous cords. The timing of differentiation is regulated by
NOTCH signaling. The functional components of the NOTCH signaling pathway are expressed and released by both developing and adult Sertoli cells. Activation of the signaling pathway is crucial for gonocyte development as it triggers gonocytes to depart from quiescence and enter into differentiation. Over activation of the pathway allows effective inhibition of quiescence and gonocyte differentiation. == Structure of gonocytes ==